Page last updated: 2024-08-22

cladribine and Pulmonary Aspergillosis

cladribine has been researched along with Pulmonary Aspergillosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Delforge, M; Dierickx, D; Janssens, A; Tousseyn, T; Vandenberghe, P; Vergote, V; Verhoef, G; Wolter, P	1

Other Studies

1 other study(ies) available for cladribine and Pulmonary Aspergillosis

Article	Year
Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib. Annals of hematology, 2014, Volume: 93, Issue:12 Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Compassionate Use Trials; Drug Resistance, Neoplasm; Humans; Imidazoles; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Targeted Therapy; Mutation, Missense; Neoplasm Proteins; Neutropenia; Oximes; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pulmonary Aspergillosis; Remission Induction; Rituximab; Salvage Therapy; Splenectomy	2014

Article

Year

Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib.

Annals of hematology, 2014, Volume: 93, Issue:12

Topics: Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cladribine; Combined Modality Therapy; Compassionate Use Trials; Drug Resistance, Neoplasm; Humans; Imidazoles; Leukemia, Hairy Cell; Male; Middle Aged; Molecular Targeted Therapy; Mutation, Missense; Neoplasm Proteins; Neutropenia; Oximes; Point Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pulmonary Aspergillosis; Remission Induction; Rituximab; Salvage Therapy; Splenectomy

2014